Fundraising Fox

Joshua Cohen

Founder

Founder at Amylyx

Canton, Massachusetts, United States

FoundedAmylyx

About

Joshua Cohen is Co-Founder and Co-CEO of Amylyx Pharmaceuticals (NASDAQ: AMLX), a company developing therapies for neurodegenerative and endocrine diseases including post-bariatric hypoglycemia, congenital hyperinsulinism, Wolfram syndrome, and amyotrophic lateral sclerosis. The company's clinical assets include avexitide, which is in Phase 3 development.

Founder at Amylyx

Intro paths

In turn, Joshua can intro founders to Amylyx's investors below.

Experience

  1. Amylyx PharmaceuticalsCo-Founder and Co-CEO at Amylyx Pharmaceuticalscurrent2013 — present
  2. NISTEngineering Researcher2012Gaithersburg, MD

Skills & more

Biomedical Engineering12Research11Biomaterials4Microfluidics3Tissue Engineering3Statistics7COMSOL4Biotechnology4Alzheimer's disease5Data Analysis4Social Media3Public Speaking5
+11 moreMatlabStataLabviewMathematicaPowerPointLabVIEWMicrosoft WordMicrosoft ExcelMicrosoft OfficePythonPharmaceutical Industry

From Joshua's professional profile.

Frequently asked questions

Who is Joshua Cohen?
Joshua Cohen is Co-Founder and Co-CEO of Amylyx Pharmaceuticals (NASDAQ: AMLX), a company developing therapies for neurodegenerative and endocrine diseases including post-bariatric hypoglycemia, congenital hyperinsulinism, Wolfram syndrome, and amyotrophic lateral sclerosis. The company's clinical assets include avexitide, which is in Phase 3 development.
Where does Joshua Cohen work?
Joshua Cohen is Founder of Amylyx.
What companies did Joshua Cohen found?
Joshua Cohen founded Amylyx.
Where did Joshua Cohen go to school?
Joshua Cohen studied at Brown University (Bachelors, Biomedical Engineering); Milton Academy (High School).

Same school

Shared employers